BBUS:XETRA:XETRA-BetaBuilders US Equity UCITS USD Acc (EUR)

ETF | Others |

Last Closing

USD 46.215

Change

-2.75 (-5.62)%

Market Cap

N/A

Volume

2.20K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-1.57 (-3.76%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

-4.33 (-4.84%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.92 (-4.33%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.47 (-3.88%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.21 (-4.39%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-1.10 (-5.26%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.60 (-5.20%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

+0.67 (+1.25%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.39 (-4.20%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.27 (-0.22%)

USD 12.26B

ETFs Containing BBUS:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -13.08% 16% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -13.08% 18% F 18% F
Trailing 12 Months  
Capital Gain 2.85% 61% D- 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.85% 62% D 61% D-
Trailing 5 Years  
Capital Gain 126.27% 92% A 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 126.27% 92% A 86% B+
Average Annual (5 Year Horizon)  
Capital Gain 17.85% 88% B+ 86% B+
Dividend Return 17.85% 88% B+ 85% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.48% 32% F 44% F
Risk Adjusted Return 115.30% 95% A 95% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.